封面
市场调查报告书
商品编码
1629614

乳酸林格注射剂市场:按配方、按容量、按年龄组、按容器、按分销管道、按地区

Lactated Ringers Injection Market, By Formulation, By Volume, By Age Group, By Container, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年,全球乳酸林格注射剂市场预计为5.101亿美元,预计到2031年将达到7.622亿美元,2024年至2031年的复合年增长率为5.9%。

报告范围 报告详情
基准年 2023年 2024年市场规模 5.101 亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率: 5.90% 2031年价值预测 7.622 亿美元
图:2024 年按地区分類的乳酸林格氏市场占有率(%)
乳酸林格注射剂市场-IMG1

乳酸林格注射是最常用的静脉注射液之一,用于恢復体液和控制脱水。有助于恢復体内电解质平衡和液体量。近年来,由于需要输注治疗的慢性疾病和损伤的盛行率不断上升,全球乳酸林格注射液市场一直稳定成长。此外,人口老化的加剧,容易出现电解质失衡,也导致乳酸林格注射液的需求增加。由于全球意识的提高和医疗保健设施的改善,预计市场在预测期内将保持良好的前景。

市场动态:

由于糖尿病、心血管疾病和肾臟疾病等经常导致电解质失衡的慢性疾病的盛行率不断上升,全球乳酸林格注射剂市场正在稳步增长。此外,道路事故、伤害和创伤的风险不断增加,以及需要紧急液体復苏的病例数量不断增加,进一步推动了市场的成长。此外,人口老化的加剧,更容易出现电解质紊乱,对乳酸林格注射液的维持需求也很高。然而,有关输液核准的严格规定可能会阻碍市场成长。此外,替代静脉注射治疗产品的可用性也是一个限制因素。同时,新兴国家不断增加的医疗保健投资为市场进入者提供了重大机会。

本研究的主要特点

本报告对全球乳酸林格注射剂市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。

它揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、业绩和策略等参数,介绍了全球乳酸林格注射剂市场的主要企业。

主要公司有 Baxter International Inc.、B. Braun Melsungen AG、ICU Medical, Inc.、Fresenius Kabi AG、Hospira, Inc.、Otsuka Pharmaceutical Co., Ltd.、Dechra Pharmaceuticals PLC、Vedco, Inc.、Grifols SA 、辉瑞公司、安进公司、Eton Pharmaceuticals, Inc.、Sagent Pharmaceuticals, Inc. 和Aurobindo Pharma Limited。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球乳酸林格注射剂市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球乳酸林格注射剂市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要进展
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业动态

第四章2019-2031年全球乳酸林格注射剂市场(依配方)

  • 标准乳酸林格氏液
  • 含添加剂(葡萄糖、氯化钠等)的乳酸林格氏液

第五章全球乳酸林格注射剂市场,依产能划分,2019-2031

  • 250ml
  • 500mL
  • 1,000ml

第六章全球乳酸林格注射剂市场,依年龄组别,2019-2031

  • 成人
  • 儿科的
  • 老年人

第7章2019-2031年全球乳酸林格注射剂市场(依货柜)

  • 塑胶瓶
  • PVC袋
  • 玻璃瓶、小瓶等

第8章2019-2031年全球乳酸林格注射剂市场(依通路)

  • 医院药房
  • 零售药房
  • 网路药房

第9章2019-2031年全球乳酸林格注射剂市场(按地区)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第10章竞争格局

  • Baxter International Inc.
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols SA
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

第十一章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十二章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7567

The global lactated ringers injection market is estimated to be valued at USD 510.1 Mn in 2024 and is expected to reach USD 762.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 510.1 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.90% 2031 Value Projection: US$ 762.2 Mn
Figure. Lactated Ringers Injection Market Share (%), By Region 2024
Lactated Ringers Injection Market - IMG1

Lactated ringers injection is one of the most commonly prescribed intravenous fluids used for fluid resuscitation and management of dehydration. It helps restore electrolyte balance and fluid volume in the body. The global lactated ringers injection market has been witnessing steady growth in the recent past due to the rising prevalence of chronic diseases and injuries that require intravenous therapy. Furthermore, the growing geriatric population who are more prone to electrolyte imbalance is also contributing to the increased demand for lactated ringers injection. With growing awareness and improved access to healthcare facilities globally, the market is expected to continue its positive outlook over the forecast period.

Market Dynamics:

The global lactated ringers injection market has been experiencing steady growth attributed to the rising prevalence of chronic health conditions such as diabetes, cardiovascular diseases, and kidney ailments that often lead to electrolyte imbalance. Additionally, the growing risk of road accidents, injuries, and trauma cases requiring emergency fluid resuscitation are further propelling market growth. Furthermore, the growing geriatric population who are more susceptible to electrolyte disorders is creating high maintenance demand for lactated ringers injection. However, stringent regulations pertaining to intravenous fluid approvals may hinder market growth. Moreover, the availability of alternative IV therapy products acts as a restraint. On the other hand, increasing healthcare investments in emerging nations provide significant opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global lactated ringers injection market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global lactated ringers injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius Kabi AG, Hospira, Inc., Otsuka Pharmaceutical Co., Ltd., Dechra Pharmaceuticals PLC, Vedco, Inc., Grifols S.A., Pfizer Inc., Amgen Inc., Eton Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., and Aurobindo Pharma Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global lactated ringers injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lactated ringers injection market

Market Segmentation

  • By Formulation Insights (Revenue, USD Mn, 2019 - 2031)
    • Standard Lactated Ringer's Solution
    • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
  • By Volume Insights (Revenue, USD Mn, 2019 - 2031)
    • 250 ml
    • 500 ml
    • 1,000 ml
  • By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
    • Adults
    • Pediatrics
    • Geriatrics
  • By Container Insights (Revenue, USD Mn, 2019 - 2031)
    • Plastic Bottles
    • PVC Bags
    • Glass Bottles/Vials etc.
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Baxter International Inc.
    • Braun Melsungen AG
    • ICU Medical, Inc.
    • Fresenius Kabi AG
    • Hospira, Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • Dechra Pharmaceuticals PLC
    • Vedco, Inc.
    • Grifols S.A.
    • Pfizer Inc.
    • Amgen Inc.
    • Eton Pharmaceuticals, Inc.
    • Sagent Pharmaceuticals, Inc.
    • Aurobindo Pharma Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lactated Ringers Injection Market, By Formulation
    • Global Lactated Ringers Injection Market, By Volume
    • Global Lactated Ringers Injection Market, By Age Group
    • Global Lactated Ringers Injection Market, By Container
    • Global Lactated Ringers Injection Market, By Distribution Channel
    • Global Lactated Ringers Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lactated Ringers Injection Market, By Formulation, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Standard Lactated Ringer's Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Lactated Ringers Injection Market, By Volume, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • 250 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 500 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 1,000 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Lactated Ringers Injection Market, By Age Group, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Lactated Ringers Injection Market, By Container, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Plastic Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • PVC Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Glass Bottles/Vials etc.
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Lactated Ringers Injection Market, By Distribution Channel, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Lactated Ringers Injection Market, By Region, 2019 - 2031, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hospira, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols S.A.
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us